April 19th 2022
Eirwen M. Miller, MD, discusses the current treatment landscape of ovarian cancer.
July 14th 2021
Eirwen M. Miller, MD, discusses the safety and efficacy of veliparib vs other PARP inhibitors used in the treatment of patients with ovarian cancer.
April 27th 2021
Eirwen M. Miller, MD, discusses the potential utility of sequential PARP inhibition in ovarian cancer.
April 2nd 2021
Eirwen M. Miller, MD, discusses her approach to frontline maintenance therapy in ovarian cancer.